Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening - Concepedia

Concepedia

Publication | Open Access

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening

DOI Full Paper Access

55

Citations

33

References

2017

Year

S. Lucas Goede, Linda Rabeneck, Marjolein van Ballegooijen, Ann G. Zauber, Lawrence Paszat, Jeffrey S. Hoch, Jean Hai Ein Yong, Sonja Kroep, Jill Tinmouth, Iris Lansdorp‐Vogelaar

Abstract

Compared to gFOBT screening, switching to FIT at a high cut-off level could increase the health benefits of a CRC screening program without considerably increasing colonoscopy demand.

References

	Year	Citations

Page 1